TCOV
PJP icon

Trust Company of Vermont’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Trust Company of Vermont’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$7.86K – 900
2022
Q4 		$7.86K Buy
+100
New +$7.69K ﹤0.01% 723

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $400M AUM 21.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Trust Company of Vermont's PJP Position: Q1 2023 in Review

Trust Company of Vermont sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2023, closing a stake of 100 shares — an estimated $7.86K sold.

Trust Company of Vermont first reported a position in PJP in Q4 2022 and held it in 1 quarter. The position peaked at $7.86K in Q4 2022. 87 funds tracked by Wall St. Rank hold PJP as of Q1 2023.

  • Trust Company of Vermont reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2023 after selling out during the quarter.
  • Trust Company of Vermont sold 100 Invesco Pharmaceuticals ETF shares in Q1 2023, an estimated $7.86K.
  • Trust Company of Vermont first reported a position in Invesco Pharmaceuticals ETF in Q4 2022 and held it in 1 quarter.
  • Trust Company of Vermont's Invesco Pharmaceuticals ETF position peaked at $7.86K in Q4 2022.
  • 87 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2023.

Based on Trust Company of Vermont's 13F filing for Q1 2023, filed 7 Apr 2023.